Lulihalt Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial dermatophytic infections such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted application to affected areas, promoting rapid symptomatic relief from itching, scaling, and inflammation associated with fungal infections. Lulihalt Cream is typically applied once daily to the cleansed and dried lesion site for a duration of 2 to 4 weeks, depending on the severity and location of the infection. It is well tolerated with minimal local adverse effects, which may include mild burning or irritation at the application site. Lulihalt Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. It is not intended for use in systemic fungal infections or mucosal candidiasis. Proper adherence to the prescribed treatment regimen is essential to prevent recurrence and ensure complete eradication of the fungal pathogen.